Literature DB >> 660265

Occlusive arteriopathy and brain tumor.

K Mori, J Takeuchi, M Ishikawa, H Handa, M Toyama, T Yamaki.   

Abstract

Four cases with the association of occlusive arteriopathy and brain tumor are presented. A clinical analysis of these cases and cases reported in the literature revealed that occlusive arteriopathy at the base of the brain was often associated with a slowly growing basal tumor in children. Possible causes of occlusive arteriopathy in these cases were compression of the circle of Willis by a slowly growing basal tumor, secondary artial occlusive changes by radiation therapy for a basal tumor, or vasculopathy associated with neurocutaneous syndrome. Symptoms of sudden onset or episodic nature suggest the presence of occlusive arteriopathy rather than the mass effect of a tumor. Cerebral angiography is mandatory whenever computerized tomography (CT), performed to rule out recurrence of a basal tumor, shows an ischemic lesion with low-density areas without any evidence of mass effect of the tumor. Cerebral angiography is also necessary when a basal tumor is suspected in children, particularly in cases associated with neurocutaneous syndrome and a basal tumor. Care should be taken not to scarify the abnormal vascular network at the base of the brain at the time of operation, because it is considered to be functioning as collateral circulation. The potential hazards of radiotherapy to radiation-induced occlusive changes of the circle of Willis must be considered in treating a benign basal brain tumor in children. Even in adults, repeated large doses of irradiation could cause occlusive arteriopathy.

Entities:  

Mesh:

Year:  1978        PMID: 660265     DOI: 10.3171/jns.1978.49.1.0022

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  13 in total

1.  Occlusion of the internal carotid artery after radiation therapy for the chiasmal lesion.

Authors:  Y Hirata; Y Matsukado; Y Mihara; M Kochi; H Sonoda; A Fukumura
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

2.  Vascular complications of cranial radiation.

Authors:  Daniel L Keene; Donna L Johnston; Laval Grimard; Jean Michaud; Michael Vassilyadi; Enrique Ventureyra
Journal:  Childs Nerv Syst       Date:  2006-04-11       Impact factor: 1.475

3.  Long-term follow-up of children with craniopharyngioma.

Authors:  N Stahnke; G Grubel; I Lagenstein; R P Willig
Journal:  Eur J Pediatr       Date:  1984-08       Impact factor: 3.183

Review 4.  Radiation therapy in the management of pediatric craniopharyngiomas--a review.

Authors:  John A Kalapurakal
Journal:  Childs Nerv Syst       Date:  2005-06-17       Impact factor: 1.475

5.  Intracranial arterial occlusion associated with high-activity iodine-125 brachytherapy for glioblastoma.

Authors:  M Bernstein; M Lumley; G Davidson; N Laperriere; P Leung
Journal:  J Neurooncol       Date:  1993-09       Impact factor: 4.130

6.  Cystic neurohypophysial germinoma associated with moyamoya disease.

Authors:  Yasushi Shibata; Masahide Matsuda; Kensuke Suzuki; Akira Matsumura
Journal:  Neurol Sci       Date:  2009-10-30       Impact factor: 3.307

7.  Giant craniopharyngioma with blindness reversed by surgery.

Authors:  B al-Wahhabi; A R Choudhury; K R al-Moutaery; M Aabed; A Faqeeh
Journal:  Childs Nerv Syst       Date:  1993-08       Impact factor: 1.475

8.  Craniopharyngiomas with unusual topography and associated with vascular pathology.

Authors:  K Mori; H Handa; T Murata; M Ishikawa; J Takeuchi; K Osaka
Journal:  Acta Neurochir (Wien)       Date:  1980       Impact factor: 2.216

9.  Moyamoya-like vasculopathy (moyamoya syndrome) in children.

Authors:  Peter Horn; Stefan Pfister; Eva Bueltmann; Peter Vajkoczy; Peter Schmiedek
Journal:  Childs Nerv Syst       Date:  2004-05-01       Impact factor: 1.475

10.  Phase II trial of conformal radiation therapy for pediatric low-grade glioma.

Authors:  Thomas E Merchant; Larry E Kun; Shengjie Wu; Xiaoping Xiong; Robert A Sanford; Frederick A Boop
Journal:  J Clin Oncol       Date:  2009-07-06       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.